CHT "ChemRar"

ChemRar High-Tech Center is a unique pharma and biotechnology conglomerate built in Russian Federation by highly innovative life science R&D organizations, discovering, developing and commercializing novel drugs for partners in Russia and worldwide. The mission of the company is to develop and commercialise existing drugs on the basis of novel “post-genomic” technologies used for treatment of cancer, infectious, cardiovascular and central nervous system (CNS) diseases as well metabolic disorders.

ChemRar performs a full cycle of pre-clinical and clinical research of new molecules including screening and identification of the essential biological targets for new molecules, synthesis and research of new molecules as well as full cycle of production.

CHT “ChemRar” presents companies performing researches in advanced laboratories fitted out with the latest equipment. The company created its own direction to equip laboratories. It made qualified nowaday laboratories and is happy to tender its services to equip laboratories for others!

Proposals to our partners:

• “Key ready” chemical laboratories, including renovation of premises, furniture manufacturing, canalization addition, vacuum, installation of balanced ventilation and electrical installation works.
• Professional ergonomic high quality furniture of standard size to be manufactured according drawings of Client: laboratory tables, chairs, closets (including exhaust fume hoods) etc.
• Creation of “clear” rooms for production and laboratory premises.

ChemRar furniture – it is a quality, ergonomics, a confidence, high working and esthetic specifications.

History of the Center began in 1990 and is associated with the name of its founder - Alexander Vasilievich Ivaschenko – a Scientific Advisor, a Doctor of Chemistry, a Professor, an Honored Innovator of the RSFSR, a Laureate of State prize of the USSR and Award of Council of Ministers of the USSR.

Within frames of this company ChemRar started works in the field of complex ordered organic synthesis for such scientific catalogue companies as Aldrich, Fluka, Acros, Merck etc. Since 1995 chemical laboratories of “Contact-Service” were among first who started absorbtion of methods for parallel and combinatorial synthesis of the libraries of organic compounds for a high-throughput screening on up-to-date biotargets with the aim to determinate theirs biological activity.

Starting from 2001 self-unique technologies and developments emerged. They were highly valued by international scientific community. Taking into consideration success of long-term cooperation, partners of “CDRI” Ltd. were proposing to find investors for establishing a research center within the territory of the RF, which would be working in the field of pre-clinic development of medical drugs. To execute this project in 2003-2004 ChemRar purchased a laboratory building which was in emergency state and was located at the site of a former national enterprise – the Research Institute of Radio and Professional Equipment in Khimki city, Moscow region – and managed to repair it within one year. As a result an advanced business-incubator of high-tech innovative companies was founded – Center of High Technologies “ChemRar”.

In 2005 on the basis of CHT “ChemRar” was established “RMPC CITOLEX” Ltd. which is working out, organizing and introducing into production the combinatorial medical drug called “SPASCARD” for self- and mutual assistance during heart attack.

Since 2007 CHT “ChemRar” in liaison with the Federal Science and Innovation Agency (ROSNAUKA) started a joint financing on a parity basis of a three-year project for development series of high efficient clinical candidates for treatment of infectious diseases. The project was set up on the basis of the Yaroslavl State Pedagogic University and called “Intellectual Dialog” Ltd.

With the object of spreading a complex of services and products for pre-clinical development of innovative medical drugs proposed by CHT “ChemRar” to its partners, in 2008 we created “Drug Technology” Ltd. on the basis of the Center and organized producing of a full cycle of import substitutive synthetic generics. In 2009 “Prudentas” Ltd. entered into the Group of companies. “Prudentas” Ltd. presents one of the leading Russian contract organization conducting early stages of clinical researches in the territory of Russia.

 

---